357 Results (Page 10 of 15)
Singapore Markets Research Reports
Singapore Biosimilar Monoclonal Antibodies Market Analysis
Singapore Biosimilar Monoclonal Antibodies Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Market drivers for biosimilar monoclonal antibodies include rising demand for low-cost biologics, the increasing frequency of chronic diseases, and the need for more economical biologic therapeutics. Among the key global pharmaceutical companies in the Biosimilar Monoclonal Antibodies Market are Samsung Bioepis Co., Celltrion Inc., Biocon Ltd., Pfizer Inc., Amgen Inc., Novartis AG (Sandoz), Mylan N.V., Boehringer Ingelheim International GmbH, Fresenius Kabi AG, and Teva Pharmaceutical Industries Ltd.
Singapore Biosimilars Market Analysis
Singapore Biosimilars Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Cost-effectiveness, patent expirations of reference biologics, increasing demand for biologic medicines, a supportive regulatory environment, and increased acceptance by healthcare professionals are all main drivers in the biosimilars market. Novartis AG, Pfizer Inc., Amgen Inc., Coherus Biosciences Inc., Mylan NV (Viatris Inc.), and Samsung Bioepis Co., Ltd. are among the top competitors in the studied market.
Singapore Blood Plasma Market Analysis
Singapore Blood Plasma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising demand for plasma-derived therapies, advancements in plasma fractionation technologies, rising awareness and adoption of plasma-derived therapies, a favourable regulatory environment, increased investment in plasma collection centres, and a growing need for blood plasma in research and development are key drivers in the blood plasma market. CSL Behring, Grifols, Octapharma, Biotest AG, and Kedrion are some of the major global competitors in the blood plasma industry.
Singapore Bone Marrow Aspirate Concentrates Market Analysis
Singapore Bone Marrow Aspirate Concentrates Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing prevalence of musculoskeletal disorders, growing awareness and acceptance of regenerative medicine, advancements in cell-based therapies, a favourable regulatory environment, and ongoing research and clinical trials exploring new applications are driving the bone marrow aspirate concentrates market. The bone marrow aspirate concentrates market is dominated by a few prominent players. Cesca Therapeutics Inc., Terumo BCT, Inc., Zimmer Biomet Holdings, Inc., and Regenexx are among the companies actively involved in the development, production, and commercialization of bone marrow aspirate concentrate products.
Singapore Burn Care Market Analysis
Singapore Burn Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing incidence of burns, driven by factors such as fire accidents, industrialization, and lifestyle changes. Additionally, Technological advancements in burn care products, including advanced dressings and wound care solutions, improving treatment outcomes have been the driving force for the market. Growing awareness, education, and healthcare expenditure, leading to increased demand for burn care services and products. Some of the global key players in the burn care market include Johnson & Johnson, 3M Company, Smith & Nephew, Mölnlycke Health Care, ConvaTec Group, Coloplast, and Derma Sciences.
Singapore Burn Ointment Market Analysis
Singapore Burn Ointment Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The burn ointment market is driven by factors such as the increasing incidence of burns, growing awareness about burn care, advancements in burn treatment technologies, rising healthcare expenditure, the aging population, and product innovations and market competition. Johnson & Johnson, Smith & Nephew plc, ConvaTec Group PLC, Medline Industries, B. Braun Melsungen AG, Derma Sciences, 3M Company, Acelity L.P. Inc., Hollister Incorporated, Molnlycke Health Care AB are among the global market leaders in Burn Ointment Market.
Singapore Cancer Supportive Care Drugs Market Analysis
Singapore Cancer Supportive Care Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030.Cancer incidence, enhanced medicines, patient-centric care, awareness, government backing, technology improvements, and an ageing population are driving the cancer supportive care medications industry. Amgen, Inc., Merck & Co., Inc., Johnson & Johnson Services, Inc., Heron Therapeutics, Inc., Novartis AG, GSK plc, F. Hoffmann-La Roche Ltd., and Helsinn Healthcare SA are among the global market leaders in cancer supportive care medications.
Singapore Cannabidiol (CBD) Market Analysis
Singapore Cannabidiol (CBD) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growing consumer demand for CBD products due to increased awareness of their potential health benefits, legalisation efforts in many regions, expanding product applications, increasing awareness and education, shifting consumer preferences toward natural alternatives, favourable regulatory environment, and growing investment and industry support are the drivers for the cannabidiol (CBD) market. CV Sciences, Elixinol LLC, Medterra, NuLeaf Naturals, and Charlotte's Web are global leaders in the Cannabidiol (CBD) market.
Singapore Cannabis Market Analysis
Singapore Cannabis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the cannabis industry include the increasing trend of legalization, both for medical and recreational purposes, which expands the market and drives demand. The growing acceptance of cannabis for medical applications, as it provides relief for various conditions, contributes to market growth. In the global cannabis market, several prominent players have established their presence. Companies such as Canopy Growth Corporation, Curaleaf Holdings, Inc., Green Thumb Industries Inc. (GTI), etc., have gained significant market share.
Singapore Carboprost Tromethamine Market Analysis
Singapore Carboprost Tromethamine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of postpartum haemorrhage, increased focus on maternal healthcare, developments in healthcare infrastructure, technological innovations in drug delivery, increasing maternal age, and supportive government initiatives are driving the carboprost tromethamine market. Pfizer Inc., Ferring Pharmaceuticals, JHP Pharmaceuticals, Hikma Pharmaceuticals, and Hemofarm A.D. are some of the leading global key competitors in the carboprost tromethamine market.
Singapore Antibacterial (Antibiotics) Drugs Market Analysis
Singapore Antibacterial (Antibiotics) Drugs Market is at around $61.09 Mn in 2023 and is projected to reach $84.82 Mn in 2030, exhibiting a CAGR of 4.8% during the forecast period. The market is expanding due to factors such as increasing population and urbanization, the development of healthcare infrastructure, and awareness initiatives and education. The market is dominated by key players like Biostadt Pharmaceuticals Pte Ltd, Pfizer Inc., AbbVie (Allergan), Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., and Teva Pharmaceuticals Industries Ltd.
Singapore Anemia Therapeutics Market Analysis
The Singapore Anemia Therapeutics Market is anticipated to experience a growth from $18 Mn in 2022 to $37 Mn by 2030, with a CAGR of 9.7% during the forecast period of 2022-2030. The Singapore Anemia Therapeutics Market is driven by rising prevalence, expanding awareness, evolving treatments, a robust healthcare system, and regional demand, though limited population and affordability hurdles remain. The Singapore Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Pfizer, AbbVie, Roche, Sanofi, AstraZeneca, Bristol-Myers Squibb, Zuellig Pharma, DKSH, Pharmaniaga etc, among various others.
Singapore Cardiovascular Drugs Market Analysis
Singapore Cardiovascular Drug Market is at around $0.17 Bn in 2022 and is projected to reach $0.23 Bn in 2030, exhibiting a CAGR of 4.4% during the forecast period. Aging population, rising prevalence of cardiovascular diseases, and increasing healthcare spending are all driving the market. The market is dominated by key players like iNova Pharmaceuticals (SGP), Eshcol Pharmaceutical Group (SGP), Wellchem Pharmaceuticals (SGP), Adjuvanz Technology (SGP), CCM Pharmaceuticals (SGP), Zydus, Pfizer Inc., Lupin, GSK, and Glenmark Pharmaceuticals.
Singapore Alopecia (Hair Loss) Therapeutics Market Analysis
The Singapore Alopecia (Hair Loss) Therapeutics Market was valued at US $10 Mn in 2022, and is predicted to grow at (CAGR) of 8.1% from 2023 to 2030, to US $18 Mn by 2030. The primary factors propelling this industry forward include the notable increase in the prevalence of alopecia (hair loss), demand for effective treatments, and others. The industry is primarily dominated by players such as Sun Pharmaceuticals, Johnson & Johnson, Capillus, Follica Inc., Lexington, and Merck, among others.
Singapore Allergy Therapeutics Market Analysis
Singapore Allergy Therapeutics Market was valued at $28 Mn in 2022 and is estimated to reach $48 Mn in 2030, exhibiting a CAGR of 7% during the forecast period. The rising incidence of allergic illnesses and the resulting health issues is fueling the growing demand for allergy therapy medications. The leading pharmaceutical companies that are presently operating in the market are GlaxoSmithKline, Novartis, AstraZeneca, Merck & Co., Sanofi, Pfizer, Johnson & Johnson, Abbott, Bayer and Boehringer Ingelheim.
Singapore Alcohol Addiction Therapeutics Market Analysis
The Singapore Alcohol Addiction Therapeutics Market is valued at around $0.86 Mn in 2022 and is projected to reach $1.46 Mn by 2030, exhibiting a CAGR of 6.9% during the forecast period. Market drivers in the Singapore Alcohol Addiction Therapeutics Market are influenced by factors like evolving treatments, private sector engagement, and a rising prevalence of alcohol-related issues among young individuals. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Singapore are Lundbeck, Otsuka Pharmaceuticals, AbbVie, Alkarmes, BioMarin, Pfizer, Mylan, Eli Lilly, AstraZeneca, GlaxoSmithKline (GSK) etc among others
Singapore Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Singapore Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $4 Mn in 2022, and is predicted to grow at (CAGR) of 8.4% from 2023 to 2030, to US $8 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, collaborations and partnerships, increased government funding initiatives, and other factors. The industry is primarily dominated by players such as Abbott, Lonza, MSD, Pfizer, Novartis, among other players
Singapore Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Singapore Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $1 Mn in 2022 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to US $2 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of autosomal dominant polycystic kidney disease, government initiatives, increased awareness and other factors. The industry is primarily dominated by players such as Alebund, AceLink, Galapagos NV, Reata, Xortx, Regulus among others
Singapore Age-Related Macular Degeneration Therapeutics Market Analysis
The Singapore Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $13 Mn in 2022, and is predicted to grow at (CAGR) of 9.50% from 2023 to 2030, to US $27 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, supportive government initiatives, and other factors. The industry is primarily dominated by players such as Roche, Regeneron Pharmaceuticals, Novartis, Bayer, and Genetech, among others
Singapore Addiction Therapeutics Market Analysis
Singapore addiction therapeutics market was valued at $12 Mn in 2022 and is estimated to reach $22 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. One of the main factors driving the addiction therapeutics market is the increase in drug awareness and prevention activities. Leading key players functioning in the market include Indivior, Alkermes, Reckitt Benckiser Pharmaceuticals, Otsuka Pharmaceutical, Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical, and Novartis AG.
Singapore Adult Malignant Glioma Therapeutics Market Analysis
The Singapore Adult Glioma Therapeutics Market is valued at around $3 Mn in 2022 and is projected to reach $5 Mn by 2030, exhibiting a CAGR of 9.5% during the forecast period. The aging population, better diagnosis and healthcare infrastructure, and more awareness among some of the factors contributing to the industry's growth, which in turn is fueling demand for treatments and creating new avenues for the glioma therapeutics market to expand. Key players in the Singapore Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Cellagenics, ASTAR, Novogene, Oncohereos Pharma etc. among others.
Singapore Sleep Disorders Market Analysis
This report presents a strategic analysis of the Singapore Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore Sleep Disorders Market, offering unmatched value, accuracy, and expert insights.
Singapore Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore Oncology Therapeutics Market will reach a value of $434 Mn from $218 Mn in 2022, growing at a CAGR of 9% during 2022-30. The Oncology Therapeutics Market in Singapore is dominated by a few domestic pharmaceutical companies such as Tessa Therapeutics, Mundipharma, and ASLAN Pharmaceuticals. The Oncology Therapeutics Market in Singapore is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Singapore Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Singapore Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore infectious disease therapeutics market will reach a value of $211.71 Mn from $143.84 Mn in 2022, growing at a CAGR of 5% during 2022-30. The Infectious Disease Therapeutics in Singapore is dominated by a few domestic pharmaceutical companies such as A*STAR Institute, Temasek Life Sciences Laboratory and Acumen Research Laboratories. The Infectious Disease Therapeutics market in Singapore is segmented into different therapeutic areas and different disease types. The major factors affecting the Singapore infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Singapore.
Singapore Home Healthcare Market Analysis
Singapore's home healthcare market was valued at $435 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022-30 and will reach $801 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by component and product. Some key players in this market are Active Global Home & Community Care, Speedoc, Variantz, Prism, Jaga-Me Medical Home Care, Homage Home Care, NTUC Health Home Care Services, and Biocomm Pte Ltd.